Tata Nifty MidSmall Healthcare Index Fund (An open-ended scheme replicating/tracking Nifty MidSmall Healthcare Index (TRI)) |
Tata Nifty MidSmall Healthcare Index Fund (An open-ended scheme replicating/tracking Nifty MidSmall Healthcare Index (TRI)) |
As on 30th November 2024
An open-ended scheme replicating/tracking Nifty MidSmall Healthcare Index (TRI)
INVESTMENT OBJECTIVE:The investment objective of the scheme is to provide returns, before expenses, that are in line with the performance of Nifty MidSmall Healthcare Index (TRI), subject to tracking error. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The scheme does not assure or guarantee any returns.
DATE OF ALLOTMENT:April 26, 2024
FUND MANAGER(S)Kapil Menon (Managing Since 26-Apr-24 and overall experience of 20 years)
BENCHMARK:Nifty MidSmall Healthcare TRI
NAV (in Rs.)Direct - Growth | : 12.4022 |
Direct - IDCW | : 12.4022 |
Reg - Growth | : 12.3461 |
Reg - IDCW | : 12.3461 |
FUND SIZE | |
Rs. 123.46 (Rs. in Cr.) | |
MONTHLY AVERAGE AUM | |
Rs. 121.71 (Rs. in Cr.) | |
TURN OVER | |
Portfolio Turnover (Equity component only) | 8.94% |
EXPENSE RATIO** | |
Direct | 0.48 |
Regular | 1.11 |
**Note: The rates specified are actual month end expenses charged as on Nov 30, 2024. The above ratio includes the Service tax on Investment Management Fees. The above ratio excludes, borrowing cost, wherever applicable. |
^Risk-free rate based on the FBIL Overnight MIBOR rate of 6.76% as
on Nov 29, 2024 For calculation methodology |
Rs. 5,000/- and in multiples of Re. 1/- thereafter.
ADDITIONAL INVESTMENT/Rs. 1,000/- and multiples of Re. 1/- thereafter.
LOAD STRUCTURE:ENTRY LOAD | Not Applicable |
EXIT LOAD |
0.25 % of the applicable NAV, if
redeemed on or before 15 days from the
date of allotment.
|
Company Name | No. of Shares | Market Value Rs Lakhs | % of assets |
Equity & Equity Related Total | 12374.92 | 100.25 | |
Healthcare Equipment & Supplies | |||
Poly Medicure Ltd. | 8513 | 236.88 | 1.92 |
Healthcare Services | |||
Max Healthcare Institute Ltd. | 166410 | 1630.40 | 13.21 |
Fortis Healthcare Ltd. | 116667 | 769.07 | 6.23 |
Syngene International Ltd. | 40396 | 380.05 | 3.08 |
Krishna Institute Of Medical Sciences Ltd. | 54957 | 324.00 | 2.62 |
Dr. Lal Path Labs Ltd. | 8243 | 247.53 | 2.00 |
Aster Dm Healthcare Ltd. | 47869 | 239.32 | 1.94 |
Global Health Ltd. | 18601 | 199.99 | 1.62 |
Narayana Hrudayalaya Ltd. | 15205 | 192.60 | 1.56 |
Rainbow Childrens Medicare Ltd. | 11161 | 177.39 | 1.44 |
Metropolis Healthcare Ltd. | 5793 | 124.06 | 1.00 |
Pharmaceuticals & Biotechnology | |||
Lupin Ltd. | 54007 | 1107.55 | 8.97 |
Aurobindo Pharma Ltd. | 62653 | 791.06 | 6.41 |
Alkem Laboratories Ltd. | 11708 | 660.62 | 5.35 |
Mankind Pharma Ltd. | 21144 | 541.54 | 4.39 |
Glenmark Pharmaceuticals Ltd. | 33738 | 515.74 | 4.18 |
Laurus Labs Ltd. | 88142 | 499.90 | 4.05 |
Ipca Laboratories Ltd. | 30405 | 469.01 | 3.80 |
Suven Pharmaceuticals Ltd. | 28436 | 371.32 | 3.01 |
Piramal Pharma Ltd. | 137838 | 370.44 | 3.00 |
Biocon Ltd. | 100742 | 367.86 | 2.98 |
Abbott India Ltd. | 1169 | 324.09 | 2.63 |
Gland Pharma Ltd. | 17815 | 309.62 | 2.51 |
Ajanta Pharma Ltd. | 9426 | 284.91 | 2.31 |
Natco Pharma Ltd. | 20290 | 279.09 | 2.26 |
J.B.Chemicals & Pharmaceuticals Ltd. | 15983 | 277.35 | 2.25 |
Glaxosmithkline Pharmaceuticals Ltd. | 9287 | 227.01 | 1.84 |
Granules India Ltd. | 32420 | 189.43 | 1.53 |
Alembic Pharmaceuticals Ltd. | 12536 | 136.92 | 1.11 |
Sanofi India Ltd. | 2037 | 130.17 | 1.05 |
Repo | 6.14 | 0.05 | |
Portfolio Total | 12381.06 | 100.30 | |
Net Current Liabilities | -34.96 | -0.30 | |
Net Assets | 12346.10 | 100.00 |
Issuer Name | % to NAV |
Max Healthcare Institute Ltd. | 13.21 |
Lupin Laboratories Ltd. | 8.97 |
Aurobindo Pharma Ltd. | 6.41 |
Fortis Healthcare Ltd. | 6.23 |
Alkem Laboratories Ltd. | 5.35 |
Mankind Pharma Ltd | 4.39 |
Glenmark Pharmaceuticals Ltd. | 4.18 |
Laurus Labs Ltd. | 4.05 |
Ipca Labs | 3.80 |
Syngene International Ltd. | 3.08 |
Total | 59.67 |
Large Cap | 4.38% |
Mid Cap | 64.95% |
Small Cap | 30.68% |
Market Capitalisation is as per list provided by AMFI. |